DOI:
10.1055/s-00000071
Seminars in Neurology
LinksClose Window
References
Rampling R, Peoples S, Mulholland PJ. , et al.
A Cancer Research UK first time in human phase I trial of IMA950 (Novel Multipeptide Therapeutic Vaccine) in patients with newly diagnosed glioblastoma.
Clin Cancer Res 2016;
22 (19) 4776-4785
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.